Yes. A person living with HIV who takes treatment and maintains an undetectable viral load has zero risk of transmitting HIV to sexual partners. This principle, known as U=U (Undetectable = Untransmittable), is backed by the CDC, the World Health Organization, and large-scale studies tracking thousands of couples over years. It is one of the most well-established findings in modern HIV science, though it comes with specific conditions worth understanding.
What “Undetectable” Actually Means
When someone with HIV takes antiretroviral therapy consistently, the medication suppresses the virus to levels so low that standard lab tests can’t measure it. Most modern tests define “undetectable” as fewer than 20 to 50 copies of HIV per milliliter of blood, depending on the lab. For context, an untreated person might have hundreds of thousands or even millions of copies per milliliter.
Reaching undetectable typically takes one to six months after starting treatment. But the status that matters for prevention, called “durably undetectable,” requires staying below that threshold for at least six months of consecutive testing. That means most people need 7 to 12 months on treatment before they can be confident their viral load is durably suppressed.
The Evidence Behind Zero Transmissions
The strongest proof comes from two landmark studies. The original PARTNER study followed couples where one partner was HIV-positive and on treatment and the other was HIV-negative. Over the course of the study, these couples reported roughly 58,000 acts of condomless sex. Not a single case of HIV transmission between partners occurred.
The follow-up PARTNER2 study focused specifically on gay male couples, tracking 76,000 additional acts of condomless anal sex (the highest-risk sexual activity for HIV transmission). Again, zero linked transmissions. While 15 HIV-negative partners did acquire HIV during the study period, genetic analysis confirmed every single infection came from someone outside the relationship, not from the partner on treatment. The combined data gave researchers high statistical confidence: the transmission rate from a partner with a suppressed viral load is effectively zero.
What Happens During Viral Blips
Even with perfect adherence, some people experience brief, small increases in their viral load called “blips.” These are defined as temporary readings between 50 and 999 copies per milliliter that return to undetectable on the next test. Blips below 500 copies per milliliter are not associated with treatment failure and generally resolve on their own.
Blips in the higher range (500 to 999 copies) carry a greater chance of eventually leading to a sustained viral rebound, which is why regular monitoring matters. But a single blip does not mean someone has become infectious. The PARTNER studies included participants who experienced blips during the study period, and still no linked transmissions occurred. What matters is the overall pattern of sustained suppression, not a single test result.
Where U=U Has Limits
U=U applies specifically to sexual transmission. The evidence is strong and definitive for vaginal sex, anal sex, and oral sex when the HIV-positive partner maintains an undetectable viral load. Outside of sex, the picture is less clear.
For sharing needles or other injection equipment, the CDC describes the risk as “unknown, but likely reduced.” There simply haven’t been large controlled studies equivalent to the PARTNER trials for this route of transmission, so the zero-risk claim cannot be made with the same certainty.
Breastfeeding is another area where U=U does not fully apply. Even with a sustained undetectable viral load, the risk of transmitting HIV through breast milk is less than 1% but not zero. Current U.S. guidelines support people who choose to breastfeed while on effective treatment, but they recommend exclusive breastfeeding for the first six months, close viral load monitoring, and stopping breastfeeding if the viral load rises above 200 copies per milliliter. This is a meaningful distinction: “almost zero” and “zero” are not the same thing when it comes to an infant.
STIs and Viral Load
One common concern is whether having another sexually transmitted infection could change the equation. STIs like gonorrhea, trichomoniasis, and bacterial vaginosis can increase the concentration of HIV in genital secretions, even when blood levels remain suppressed. This happens because STIs cause inflammation and attract immune cells (the very cells HIV infects) to the genital area.
In people not on treatment, this effect significantly raises transmission risk. For people on effective antiretroviral therapy with undetectable blood viral loads, the clinical significance is less certain. The PARTNER studies did not exclude people with STIs, and still found zero transmissions. That said, treating STIs promptly remains important for overall health and for reducing any theoretical residual risk.
What Keeps U=U Working
The “untransmittable” part of U=U depends entirely on the “undetectable” part, which depends on consistent treatment. Missing doses, running out of medication, or stopping treatment can allow the virus to rebound, sometimes within days to weeks. Once viral load rises above undetectable levels, the zero-risk guarantee no longer applies.
Regular viral load testing, typically every three to six months for people who are stable on treatment, confirms that suppression is holding. This is not a one-time achievement. It is an ongoing status that requires ongoing medication. For people who maintain it, the science is unambiguous: they cannot pass HIV to their sexual partners.